Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)

Clinical trial NCT00001785 · COMPLETED

Trial details

NCT number: NCT00001785
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

HTLV-I Infection Spinal Cord Disease Tropical Spastic Paraparesis

Start date: 1998-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.